Pacific Biosciences of California Inc
NASDAQ:PACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Sligro Food Group NV
AEX:SLIGR
|
NL |
|
M
|
MyTech Group Bhd
KLSE:MYTECH
|
MY |
|
Jason Furniture Hangzhou Co Ltd
SSE:603816
|
CN |
|
H
|
Hanger Inc
F:HO8
|
US |
|
P
|
Pegasus Heights Bhd
KLSE:PHB
|
MY |
|
C
|
China Vast Industrial Urban Development Company Ltd
HKEX:6166
|
HK |
|
M
|
Ming Le Sports AG
F:ML2
|
DE |
|
A
|
Axactor ASA
OSE:ACR
|
NO |
|
Charter Hall Group
ASX:CHC
|
AU |
Wall Street
Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for
PACB
is 2.3 USD
with a low forecast of 1.01 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PACB's stock price target?
Price Target
2.3
USD
According to Wall Street analysts, the average 1-year price target for
PACB
is 2.3 USD
with a low forecast of 1.01 USD and a high forecast of 3.15 USD.
What is Pacific Biosciences of California Inc's Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Pacific Biosciences of California Inc's revenue is
12%.
The projected
CAGR
for the next 3 years is
13%.
